Literature DB >> 15276190

Olanzapine-induced delirium in a terminally ill cancer patient.

Tatsuya Morita, You Tei, Hideki Shishido, Satoshi Inoue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15276190     DOI： 10.1016/j.jpainsymman.2004.04.008

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  2 in total

1.  Delirium associated with olanzapine therapy in an elderly male with bipolar affective disorder.

Authors:  Ravi C Sharma; Ashish Aggarwal
Journal:  Psychiatry Investig       Date:  2010-05-18       Impact factor: 2.505

2.  Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Jian-Guo Zhou; Lang Huang; Su-Han Jin; Cheng Xu; Benjamin Frey; Hu Ma; Udo S Gaipl
Journal:  ESMO Open       Date:  2020-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.